Search keyword concepts
|
Selected filters
|
- 96,050 - 96,100 out of 101,388 results
- Export search results
Search results
-
Antioxidanter i frugt og grønt - har det en sundhedseffekt?
Lars Porskjær Christensen (Lecturer)
10. Jun 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Anti-osteoporotiske behandling i Danmark: en register baseret undersøgelse af recept-indløst compliance og persistence
Carrinna Hansen (Lecturer)
9. Nov 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Anti-osteoporotiske behandling i Danmark: en register baseret undersøgelse af lav recept-indløst compliance og persistence
Carrinna Hansen (Lecturer)
29. Nov 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antinukleære antistoffer og bindevævssygdomme i Region Sønderjylland
Carsten Demant Sørensen (Lecturer)
13. May 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antinous - en glemt homomyte
Dag Heede (Guest lecturer)
9. Mar 2017Activity: Talks and presentations › Talks and presentations in private or public companies
-
"Anti-narrativity - A Phenomenological Challenge or Challenging Phenomenology?"
Anita Nell Bech Albertsen (Lecturer)
2. May 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antimicrobial effects of selectet non-antibiotics
Oliver Hendricks (Lecturer)
4. Jun 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulerende behandling
Anna-Marie Bloch Münster (Lecturer)
29. Nov 2017Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulationsbehandling - hvilket præparat skal man vælge, Vejle Sygehus
Ivan Brandslund (Lecturer)
6. Sep 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulationsbehandling - hvilket præparat skal man vælge
Ivan Brandslund (Lecturer)
3. Nov 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulationsbehandling - hvilket præparat skal man vælge
Ivan Brandslund (Lecturer)
26. Aug 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulantia - pause hvornår?
Anna-Marie Bloch Münster (Lecturer)
17. Nov 2018Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikoagulansbehandling - nye og gamle midler
Jane Skov (Lecturer)
18. Feb 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antikfagene i Danmark
Christian Høgel (Lecturer)
17. Sep 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Anti-inflammatory compounds in rose hips from Rosa canina L. (speciale)
Lars Porskjær Christensen (Censor)
30. Jun 2009Activity: Examination
-
Anti-human CD73 mAb cause CD73 internalization and inhibit metastasis formation of human breast cancer
Mikkel Green Terp (Lecturer)
27. Apr 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antihistamines update
Carsten Bindslev-Jensen (Lecturer)
23. Jun 2013Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antihistamines in urticaria
Carsten Bindslev-Jensen (Lecturer)
1. Mar 2007Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antigone: en kvindes dillema
Harry Haue (Lecturer)
5. May 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antigone
Lærke Andersen (Lecturer)
4. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antifospholipid antistoffer: anti-β2-glykoprotein I og anticardiolipin antistoffer
Vakur Bor (Lecturer)
25. Nov 2016Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antiemetic therapy in patients with lung cancer
Jørn Herrstedt (Lecturer)
3. Jul 2011 → 7. Jul 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antiemetics: State of the Art
Jørn Herrstedt (Lecturer)
20. Sep 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
antiemetic guidelines: Acute nausea and vomiting: moderately emetogenic chemotherapy
Jørn Herrstedt (Lecturer)
19. Jun 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antidepressiv behandling: Fra klinisk forskning til klinisk hverdag
Kurt Bjerregaard Stage (Lecturer)
6. May 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antichrists og den dæmoniske natur
Torsten Bøgh Thomsen (Guest lecturer)
15. Apr 2015Activity: Talks and presentations › Guest lectures, external teaching and course activities at other universities
-
Anti-CD73 antibodies inhibit formation of metastasis in breast cancer
Mikkel Green Terp (Lecturer)
19. Jan 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Anti-CCP and Rheumatoid arthritis
Kim Hørslev-Petersen (Lecturer)
17. Jun 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibodies as tools in cancer immunotherapy.
Henrik Ditzel (Lecturer)
9. Jun 2016Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotisk behandling ved elektiv operation for kolorektal cancer og akut kolonkirurgi
Niels Qvist (Other)
21. Apr 2006Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotikaanvendelse i urologien
Per Søgaard (Participant)
26. Mar 2009Activity: Other activities › Other
-
Antibiotika - vor tids mirakler på flasker
Carl Th. Pedersen (Lecturer)
26. Mar 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotikavejledning i pro.medicin: A-kursus for kommende speciallæger i klinisk mikrobiologi
Bente Gahrn-Hansen (Guest lecturer)
7. May 2012Activity: Talks and presentations › Guest lectures, external teaching and course activities at other universities
-
Antibiotikaresistente bakterier i husdyrproduktionen: konsekvenser for sundhedsvæsnet
Hans Jørn Kolmos (Lecturer)
26. Aug 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika-resistente bakterier: Hvordan vinder vi våbenkapløbet?
Hans Jørn Kolmos (Lecturer)
2. Apr 2019Activity: Talks and presentations › Talks and presentations in private or public companies
File -
Antibiotika-resistente bakterier: Hvad er udfordringen? Hvordan vinder vi våbenkapløbet?
Hans Jørn Kolmos (Lecturer)
24. Sep 2020Activity: Talks and presentations › Talks and presentations in private or public companies
File -
Antibiotikaresistens i et "one Health" perspektiv
Hans Jørn Kolmos (Lecturer)
19. Apr 2017Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika på pro.medicin
Bente Gahrn-Hansen (Guest lecturer)
7. May 2012Activity: Talks and presentations › Guest lectures, external teaching and course activities at other universities
-
Antibiotikaprofylakse og den nye operationsstandard DS 2451-5 - Hvad er nyt?
Niels Qvist (Lecturer)
9. Nov 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika mod farlige infektioner - vi vandt slaget, men tabte vi krigen?
Hans Jørn Kolmos (Lecturer)
15. Sep 2016Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika mod farlige infektioner: vi vandt slaget, men taber vi krigen?
Hans Jørn Kolmos (Lecturer)
31. Jan 2016Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika mod farlige infektioner
Hans Jørn Kolmos (Lecturer)
31. Jan 2017Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotikaforbrug i husdyrproduktionen: konsekvenser for sundhedsvæsenet
Hans Jørn Kolmos (Participant)
27. May 2011Activity: Other activities › Other
-
Antibiotikaforbrug forud for samfundserhvervede urinvejsinfektioner med extended-spectrum β-lactamase (ESBL) Escherichia coli [Antibiotic consumption prior to community-acquired urinary tract infections with extended-spectrum β-lactamase (ESBL) Escherichia coli]
Kim Oren Gradel (Lecturer)
28. Apr 2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotikabehandling af ældre - herunder multiresistens
Hans Jørn Kolmos (Lecturer)
7. Mar 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotikabehandling af ældre: herunder multiresistens
Hans Jørn Kolmos (Speaker)
7. Mar 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotika: hvordan sikrer vi vejen frem i en tid med stigende resistens
Hans Jørn Kolmos (Lecturer)
18. Nov 2016Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotic resistance in bacteria - studies of molecular resistance mechanisms preventing inhibition of protein synthesis
Birte Vester (Lecturer)
11. Jun 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotic resistance: Setting the scene
Hans Jørn Kolmos (Lecturer)
18. Mar 2013Activity: Talks and presentations › Talks and presentations in private or public companies
-
Antibiotic resistance: Extent, causes and consequences
Hans Jørn Kolmos (Lecturer)
21. May 2012Activity: Talks and presentations › Talks and presentations in private or public companies